BINEX Co., Ltd.

BINEX Co., Ltd.

Share · KR7053030003 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BINEX Co., Ltd.
No Price
Closing Price XKOS 29.04.2026: 11.420,00 KRW
29.04.2026 06:30
Current Prices from BINEX Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
053030.KQ
KRW
29.04.2026 06:30
11.420,00 KRW
-150,00 KRW
-1,30 %
Share Float & Liquidity
Free Float 86,57 %
Shares Float 27,57 M
Shares Outstanding 31,85 M
Invested Funds

The following funds have invested in BINEX Co., Ltd.:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
54,37
Percentage (%)
0,05 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
29,20
Percentage (%)
0,0094 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
147,81
Percentage (%)
0,0094 %
Company Profile for BINEX Co., Ltd. Share
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.

Company Data

Name BINEX Co., Ltd.
Company BINEX Co., Ltd.
Website https://www.bi-nex.co.kr
Primary Exchange XKOS KOSDAQ
ISIN KR7053030003
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Won-Seok Kim
Market Capitalization 368 Mrd.
Country South Korea
Currency KRW
Employees 0,6 T
Address 7-48 SongDo-Dong, 406-840 Incheon
IPO Date 2001-08-07
Dividends from 'BINEX Co., Ltd.'
Ex-Date Dividend per Share
29.12.2008 200,00 KRW
27.12.2007 200,00 KRW
28.12.2005 200,00 KRW

Stock Splits

Date Split
02.05.2011 2:1
07.08.2009 221:200
20.09.2005 1071:1000

Ticker Symbols

Name Symbol
KOSDAQ 053030.KQ
More Shares
Investors who hold BINEX Co., Ltd. also have the following shares in their portfolio:
DNB BANK 22/33 FLR MTN
DNB BANK 22/33 FLR MTN Bond
K.P. Energy Limited
K.P. Energy Limited Share